Skip to main content
Toggle navigation
Login
Home
Back
Favorite
0
Like
Facebook
Tweet
Session VIII: Landscape Shift in mHSPC and nmCRPC
Debate: Treatment of Men with Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): Metastasis Directed Therapy vs Systemic Therapy - METASTASIS DIRECTED THERAPY IS PREFERRED
Friday, September 30, 2022
1:45 PM – 1:52 PM
Debate Speaker(s)
Neha Vapiwala, MD, FACR, FASTRO
Penn Medicine, Hospital of the University of Pennsylvania